IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Administrative / Procedural, Good Clinical Practice (GCP)
Published
February 27, 2012
Last updated
April 24, 2020
Description
This document provides guidance on IRB continuing review after clinical investigation approval, targeting IRBs, investigators, and sponsors.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)